Compounded Tirzepatide – 17mg Weekly Dose (4-Week Vial)

This compounded tirzepatide vial provides a full 4-week supply at a 17mg weekly dose. Total peptide content is 68mg per vial (17mg × 4 weeks).
One vial equals one complete 4-week supply.

Clinical note:
This is a supra-therapeutic dose. The highest commercially available FDA-approved tirzepatide dose is 15mg. The 17mg dose requires provider approval and is reserved for select cases where the maximum commercial dose has not been adequate in helping a patient reach a medically appropriate goal BMI.

Product details:
• Weekly dose: 17mg
• Total peptide: 68mg per vial (17mg × 4 weeks)
• Supply: 4 weeks
• Price: $499
• Compounded in a pharmacy following USP standards
• COA-backed sterility, potency, and quality testing

Important notes:
• Requires active membership for purchase ($25/month, cancel anytime)
• Requires completion of a medical intake form and provider review
• For use only under medical supervision; prescribing is based on provider judgment
• Compounded medications are not FDA approved
• This compounded tirzepatide is not associated with or manufactured by Eli Lilly and is not the FDA-approved products Mounjaro or Zepbound
• Not for use during pregnancy or breastfeeding

*Patients must be physically located in a state where our providers are licensed at the time of prescribing; once prescribed, medication may be shipped to all 50 states.
(States: CA, FL, KY, ME, MA, MI, MN, MT, NV, NH, NY, OH, RI, SC, TX, UT, WY, CO, NC, IN, NE)